Expanding into new markets With recent key appointments like Philip Wong as President of Greater China Region and the launch of a liposomal skincare system, Vasayo is poised to expand into the Greater China market and capitalize on the growing demand for innovative skincare solutions.

Utilizing CBD trend Vasayo has strategically positioned itself in the CBD market with the launch of CBD ONE and has been recognized as a top five healthcare company globally. Leveraging the popularity of CBD products presents a lucrative sales opportunity for Vasayo to further enhance its market presence and reach a wider consumer base.

Enhancing scientific credibility The appointment of Dr. Dan Gubler as Chief Scientific Officer strengthens Vasayo's scientific advisory board, enhancing the credibility and quality of its products. This move opens doors for Vasayo to engage with a more scientifically inclined customer base and drive sales through evidence-based marketing strategies.

Product diversification strategy By launching a complete liposomal skincare system and expanding its product range, Vasayo displays a commitment to diversification. This strategic move not only allows Vasayo to cater to a wider audience but also presents cross-selling opportunities and boosts overall sales revenue.

Competitive positioning & recognition Vasayo's recognition as a top healthcare company globally and its continuous efforts to appoint key executives like Troy Mohr as Senior VP of Global Operations highlight its strong competitive positioning. Leveraging this reputation in sales pitches can help Vasayo gain trust with potential clients and partners, leading to increased sales opportunities.